RECENT NEWS

2015 November 2

November 27 –  28, 2015 Grand Hotel Salerno – Sala Cilento via Lungomare Tafuri, 1, 84127 Salerno

2015 February 26

2015/02/20 Aula F. Ferro – Polo Universitario Azienda Ospedaliera – Universitaria “San Giovanni Di Dio e Ruggi D’Aragona”…

2015 February 12

AEPC 2015 49th Annual Meeting of the Association for European Paediatric and Congenital Cardiology. May 20-23 – 2015…

Grants Committee

The Grants Committee’s role is to support investigators making grant applications. It provides direction to grant proposals and assesses each application for applicability to BAVCon’s goals and use of BAVCon resources.

Patrick Mathieu
Co-Chair
Giuseppe Limongelli
Co-Chair

Dr. Giuseppe Limongelli graduated (1997) and completed his Cardiology Training (2001) at the Second University of Naples (SUN). From 2002 to 2003, he was Research Fellow of The Genotyping Lab & Heart Failure Clinic at St George’s Hospital Medical School (London, UK). From 2003 to 2004, he was Research Fellow of the Cobbold Lab (Middlesex Hospital) & Heart Failure Clinic (The Heart Hospital) University College of London (London, UK). He completed a 3 year Phd course at Secondd University of Naples in 2003. He was appointed with the title of “European Doctor in Biotechnology” in 2007 (HeduBT, UK). He is a member/fellow of national and international cardiovascular societies (SIC; ESC; HFA; AHA). Since February 2011, he is Editor in Chief of a new open access, online journal, Cardiogenetics. Since 2013, he is member of the World Association of Medical Editors (WAME). He is currently an assistant professor of cardiology at the Second University of Naples, and consultant cardiologists, at the Department of Cardiology, Monaldi Hospital. His main interests concern the field of inherited heart diseases, congenital heart diseases, and rare cardiovascular diseases.

Bo Yang

Dr. Bo Yang has recently taken over the role of principal investigator of the Bicuspid Aortic Valve Registry at the University of Michigan’s Frankel Cardiovascular Center. Dr. Yang is working in conjunction with cardiologists and other surgeons at the University of Michigan to build a BAV registry from which to share and research data from. Dr. Yang’s research includes projects to determine the mechanism of thoracic aortic aneurysm formation in patients with BAV. By modeling the human BAV-disease with induced pluripotent stem (iPS) cell technology, the mechanism can be studied and in the future, patient specific tissue engineered vascular grafts can be generated. Dr. Yang’s research and clinical practice include both researching and providing care to BAV patients and working to minimize the serious complications that BAV patients are predisposed to.

Gordon Huggins

Dr Huggins’ laboratory is supported by a grant from the National Institutes of Health to study Bicuspid Aortic Valve disease and Calcific Aortic Valve Disease. Dr Huggins’ laboratory has previously performed a pathway-based genome-wide association study that identified several genes associated with bicuspid aortic valve. His current work focuses on a regulator of bone formation and the role that gene plays in hardening of the aortic valve which can lead to aortic valve stenosis. In addition to his role directing a research laboratory Dr Huggins is a practicing Cardiologist on staff at Tufts Medical Center Cardiology Division who cares for patients with aortic valve disease.

Maria Grazia Andreassi
Philippe Pibarot
Simon Body

Dr. Body is an Associate Professor of Anesthesiology at Harvard Medical School and a cardiac anesthesiologist with research expertise in genomics of bicuspid aortic valve disease and atrial fibrillation.
Dr. Body’s clinical responsibilities at Brigham and Women’s Hospital include cardiac anesthesia and transesophageal echocardiography. Dr. Body mentors cardiac anesthesia fellows and residents who have a special interest in genetics, and medical students. Dr. Body is Principal Investigator for the Bicuspid Aortic Valve Consortium (BAVCon) and the Perioperative Genomics Research Network (PeriGReN).